Abstract: A water curtain head according to the present invention may comprise: a head body which is connected to a water supply pipe installed in an inner side of a building and has a water-releasing opening; and a deflector arranged adjacent to the water-releasing opening to allow water discharged by the water-releasing opening to pass therethrough. The deflector may comprise: a first spray nozzle formed on the front surface of the deflector to penetrate the front surface of the deflector; and a second spray nozzle formed to be recessed inward from a side surface of the deflector by a predetermined section.

Abstract: The purpose of the present invention is to develop a cucumber fruit mottle mosaic virus vector so as to enable a study of gene function through gene silencing phenomenon in Cucurbitaceae plants, which has been difficult to study in the past, and to enable the study in fruits as well through stable expression. Furthermore, the present invention establishes a system that enables expression of a heterologous protein in plants, thereby, for the first time, providing a vector applicable to both the gene silencing phenomenon and protein expression in Cucurbtaceae plants.

Abstract: The present invention relates to a production method for a glassy carbon mold, and, more specifically, relates to a production method for a glassy carbon mold including the steps of: placing a mixture having a thermosetting resin, a curing agent, and a viscosity adjusting solvent between a thermosetting resin substrate and a master pattern formed by a micro-nano process; pressing either the master pattern or the thermosetting resin substrate and applying heat to form a cured thermosetting resin pattern part on the substrate; and removing the master pattern, and subjecting the substrate and the cured thermosetting resin pattern.

Abstract: The present invention directs to a method for treating a smooth muscle cell proliferative disease by using a recombinant expression vector comprising a polynucleotide encoding FGF12, or by using FGF12 protein or a fragment thereof; and a method for detecting a marker for diagnosis of smooth muscle cell proliferative disease, comprising the measurement of FGF12 expression level.

Abstract: Provided is an image sensor. The image sensor includes a pixel array including a plurality of pixel blocks. Each of the plurality of pixel blocks includes a plurality of pixels arranged in a matrix form. Each of the plurality of pixels includes a plurality of phase difference sensing pixels. Each of the plurality of phase difference sensing pixels may be periodically repeatedly arranged in the pixel array in a horizontal direction and a vertical direction.

Abstract: The present invention relates to a formulation for external application to the skin containing tacrolimus, which is a poorly soluble drug used as a second therapeutic agent for atopic dermatitis and, more specifically, to a composition of a hydrophilic external gel formulation capable of enhancing skin permeability of tacrolimus, and a preparation method therefor. The hydrophilic external gel formulation loaded with tacrolimus of the present invention is in an easily preparable practical form with excellent moisturizing performance, and is excellent in spreadability and has improved drug delivery, skin permeability and skin residual capacity when applied to the skin, compared to conventional ointments, and thus can be usefully used for the treatment of atopic dermatitis and other immune diseases.

Abstract: The present invention provides a pharmaceutical composition for the prevention or treatment of glaucoma, wherein the pharmaceutical composition includes angiogenin or a fragment thereof as an active ingredient. Angiogenin or a fragment thereof according to the present invention activates aqueous humor outflow due to NO generation increase, Schlemm's canal expansion, and intercellular interval widening, thereby reducing intraocular pressure. Accordingly, angiogenin and a fragment may be useful for the prevention and treatment of glaucoma.

Abstract: A method and an apparatus for restoring a motion blurred image are disclosed. The method of restoring a motion blurred image comprises calculating a motion trajectory and a project trajectory of a camera using an embedded sensor; estimating a point spread function according to camera motion by using the motion trajectory and the project trajectory; and restoring the motion blurred image using the estimated point spread function and a spatially variant activity map.

Abstract: Disclosed are stem cells having a thin multilayer structure, a method of preparing the same, and use thereof for cytotherapy. In accordance with the present invention, stem cells with a thin multilayer structure having improved stability and controlled multifunctionality are provided. A method of preparing the stem cells having the thin multilayer structure according to the present invention is very simple, and thus, the stem cells having the thin multilayer structure can be produced at low cost and high efficiency. Therefore, the stem cells having the thin multilayer structure prepared according to the present invention are very useful as a stem cell therapy agent for treating various diseases.

Abstract: The present invention relates to an apparatus and method for providing a virtual treatment experience which can make a user to understand the necessity for treatment and learn how to counteract side effects of the treatment.

Abstract: Disclosed is an active energy harvesting device. The device includes a rigid body configured to vibrate corresponding to vibration of an external vibration body and including a first end at which an energy harvesting structure is provided to convert mechanical energy into electric energy, a magneto-rheological material provided at a second end of the rigid body to be bound to the rigid body and including a material which is changed in elastic force according to the surrounding magnetic field strength, a fixing unit for binding the second end of the rigid body and the magneto-rheological material and connecting the rigid body to the external vibration body, and a first permanent magnet arranged symmetrically apart from the magneto-rheological material while interposing the magneto-rheological material therebetween and provided so as to adjust a gap from the magneto-rheological material and change an elastic coefficient of the magneto-rheological material according to the gap.

Abstract: The present invention relates to a novel 2-aminothiazole derivative, N-(5-(4-fluorophenyl)thiazole-2-il)-3-(furan-2-il)propane amide and to a use thereof as an anti-cancer drug. It is verified that the compound of the present invention has highly superior cancer cell-specific cytotoxic activity and in-vivo anti-cancer activity for inhibiting the growth of tumors in an animal model for cancer disease, and therefore can be developed as an anti-cancer candidate substance.

Abstract: The present invention relates to a method of predicting animal litter size using a fertility-related protein marker, and more particularly, to the discovery of a sperm marker that is expressed differently depending on animal fertility, a marker composition for predicting litter size, which comprises an antibody that binds specifically to the marker, and a method of predicting animal litter size using the marker composition. Moreover, the present invention relates to a method of predicting animal semen quality and litter size by chlortetracycline staining, and more particularly, to a method of predicting of animal litter size by measuring the motility, motion kinematics or capacitation status of sperm. When the animal sperm-derived protein marker according to the present invention is used, the litter size of individuals can be predicted by analyzing a protein that is expressed differently depending on litter size.

Abstract: A pharmaceutical composition for preventing or treating ovary granulosa cell tumors containing, as an active ingredient, one selected from the group consisting of a compound represented by chemical formula 1, a pharmaceutically acceptable salt of the compound represented by chemical formula 1, a compound represented by chemical formula 2, and a pharmaceutically acceptable salt of the compound represented by chemical formula 2, or a functional health food composition. The composition inhibits glycogen synthase kinase-3 beta (GSK3beta) and thus has an effect of inhibiting a phosphorylation of a serine, which is the 33rd amino acid of the forkhead box L2 (FOXL2) protein.

Abstract: A catalyst carrier for purification of exhaust gas, may include a substrate having a plurality of cell paths partitioned by a cell barrier rib and a ceramic coating layer positioned on the inside surface of the cell path, where the ceramic coating layer has a porous lamellar structure arranged in an exhaust gas flow direction, and a method for preparing the same.

Abstract: This disclosure relates to microspheres emboli and method of making them. The recoverability of lyophilized microspheres is optimized by adding trehalose prior to lyophilization of the microspheres and vortexing the lyophilized microspheres. The optimization can be useful in maintaining physical properties, shapes, and the drug release level of the microspheres for emboli. Chitosan microspheres can be useful in stably causing emboli in blood vessels, and precisely adjusting the release of a drug, and thus can be used in anticancer treatment.

Abstract: The present invention provides a pharmaceutical composition for the prevention or treatment of glaucoma, wherein the pharmaceutical composition includes angiogenin or a fragment thereof as an active ingredient. Angiogenin or a fragment thereof according to the present invention activates aqueous humor outflow due to NO generation increase, Schlemm's canal expansion, and intercellular interval widening, thereby reducing intraocular pressure. Accordingly, angiogenin and a fragment may be useful for the prevention and treatment of glaucoma.

Abstract: This invention is a method for improving production yield of HPV L1 protein including the phase of culturing cell expressing HPV L1 protein in a medium containing high concentration of carbon source. According to the culture method using a medium containing highly concentrated carbon source of this invention, the production yield of HPV L1 protein can be not only remarkably increased but also the immunogenicity of the produced HPV L1 protein is significantly increased.

Abstract: This invention is a method for improving production yield of HPV L1 protein including the phase of culturing cell expressing HPV L1 protein in a medium containing high concentration of carbon source. According to the culture method using a medium containing highly concentrated carbon source of this invention, the production yield of HPV L1 protein can be not only remarkably increased but also the immunogenicity of the produced HPV L1 protein is significantly increased.

Abstract: The present invention relates to a composition for treating a bacterial infection comprising an extract from a bark of Alnus pendula, or diarylheptanoid compound as an active ingredient. The extract from a bark of Alnus pendula, diarylheptanoid compound of the present composition has a remarkably excellent anti-bacterial activity against bacteria, specifically Staphylococcus aureus. Therefore, the extract and compound of the present invention may be utilized as an active ingredient of drug, cosmetics, functional food and animal feed for treating bacterial infection, in particular an infection of S. aureus.